Fintech funding in India continued its downward trend this year, carrying on a trend that started in 2022 as rising interest rates, fears of...

Payments fintech Payoneer is building out “direct-to-consumer”, or D2C, services in a bid to outflank bigger rivals such as Stripe and PayPal. For the...

Today, most merchants looking to sell a product or service online can quickly get their payment system live with the help of a modern...

SEF trading accounted for 77% of USD swap trading in 2022. This was despite there being no “MAT” trading in USD swaps during 2022....

Transformative ecommerce metaverse will improve the web buying expertise and produce real-world adoption to the metaverse tradeNFT-based luxurious life-style metaverse enabler Trace Network Labs...

Customers want seamless digital finance experiences when shopping for a vehicle, yet traditional and even new direct-to-consumer (D2C) manufacturers are slow to offer true...

CORRA First was put in place on January 9th 2023 to help CAD interest rate derivatives transition from CDOR to CORRA. For all of...

The USD 200 trillion B2B payments flow is rapidly moving towards a ‘checkout’ experience similar to B2C payments. For banks, the resulting digital data...

Late last year, on Dec 5th, US Swap Data Repositories (SDRs) went live with CFTC’s amended swap data reporting framework (a.k.a CFTC re-write). This...

Few people in developed economies remain untouched by the gig economy. Whether that’s directly through working in it (like 3 in 20 of UK...

As the line between web and traditional retail store fulfillment blurs, brands need to assess their fulfillment capabilities and those of their 3PL multi-channel distribution partners.

Consumers prefer to be channel agnostic. They want to complete a purchase and receive/return the product to and from any channel they choose. And they want the brands they buy from to align their businesses to make that happen.

Are brands there yet? Let’s say they’re evolving.

Radicle Science launches several blinded placebo-controlled clinical trials on rare cannabinoids with 10,000 participants in the first half of 2022 on the heels of completing 25 large-scale CBD studies in 2021. SAN DIEGO–(BUSINESS WIRE)–#cannabinoids—Radicle Science, a transformative healthtech B-corp validating health and wellness products for the first time, will launch history’s first large-scale, blinded, placebo-controlled […]

The post Radicle Science Makes History Again With First Large-Scale Clinical Trials on Rare Cannabinoids, Including THCV, CBN, CBG, and CBC appeared first on Fintech News.